Félix Omeñaca Terés-rekin lankidetzan egindako argitalpenak (7)

2012

  1. Five-year antibody persistence and safety following a booster dose of combined haemophilus influenzae type b-neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1074-1077

2011

  1. Combined haemophilus influenzae type B-neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 11

2008

  1. Immunogenicity and reactogenicity of a booster dose of a novel combined haemophilus influenzae type b-neisseria meningitidis serogroup c-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age

    Pediatric Infectious Disease Journal, Vol. 27, Núm. 7, pp. 579-588

2007

  1. Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 1, pp. 1-7

2006

  1. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 8, pp. 713-720

1991

  1. ASOCIACION ESPANOLA DE PEDIATRIA. MADRID. INFECCION POR EL VIRUS DE LA INMUNODEFIENCIA HUMANA. ENCUESTA MULTICENTRICA ESPANOLA

    Anales Espanoles de Pediatria, Vol. 34, Núm. 6, pp. 425-435

1990

  1. SIDA PEDIATRICO EN ESPANA

    Anales Espanoles de Pediatria, Supplement